Basics Instil Bio, Inc. IPO Date: March 19, 2021 Sector: Healthcare Industry: Biotech Market Cap: $136.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.71 | 4.37% Avg Daily Range (30 D): $1.04 | 4.87% Avg Daily Range (90 D): $1.39 | 5.43% Institutional Daily Volume Avg Daily Volume: .32M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .17M Trade Size Avg Trade Size (Sh.): 104 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 66 Institutional Trades Total Inst.Trades: 192 Avg Inst. Trade: $2.21M Avg Inst. Trade (30 D): $1.01M Avg Inst. Trade (90 D): $1.05M Avg Inst. Trade Volume: .02M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.85M Avg Closing Trade (30 D): $.58M Avg Closing Trade (90 D): $1.01M Avg Closing Volume: 36.19K     News Aug 13, 2025 @ 11:09 AM Instil Bio Posts Wider Loss in Q2 Source: Jesterai Jul 7, 2025 @ 5:00 PM Bispecific Antibody Clinical Trial Pipeline Gains ... Source: Delveinsight Jun 11, 2025 @ 11:00 AM Instil Bio Names John Maraganore, Ph.D., to Board ... Source: N/A May 22, 2025 @ 10:00 AM Instil Bio and ImmuneOnco Announced the Phase 2 Tr... Source: N/A May 13, 2025 @ 11:00 AM Instil Bio Reports First Quarter 2025 Financial Re... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-11.97 $-4.32 $-1.82 Diluted EPS $-11.97 $-4.32 $-1.82 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -78.03M $ -28.2M $ -11.9M Operating Income / Loss $ -80.15M $ -30.56M $ -11.82M Cost of Revenue $ $ $ Net Cash Flow $ 5.57M $ 5.69M $ 3.97M PE Ratio     Splits Dec 08, 2023:   1:20